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Dyspnea and exercise limitation are among the most common symptoms experienced
by patients with various chronic lung diseases and are linked to poor quality of life. Our
understanding of the source and nature of perceived respiratory discomfort and exercise
intolerance in chronic lung diseases has increased substantially in recent years. These
new mechanistic insights are the primary focus of the current review. Cardiopulmonary
exercise testing (CPET) provides a unique opportunity to objectively evaluate the ability
of the respiratory system to respond to imposed incremental physiological stress.
In addition to measuring aerobic capacity and quantifying an individual’s cardiac
and ventilatory reserves, we have expanded the role of CPET to include evaluation
of symptom intensity, together with a simple “non-invasive” assessment of relevant
ventilatory control parameters and dynamic respiratory mechanics during standardized
incremental tests to tolerance. This review explores the application of the new advances
in the clinical evaluation of the pathophysiology of exercise intolerance in chronic
obstructive pulmonary disease (COPD), chronic asthma, interstitial lung disease (ILD) and
pulmonary arterial hypertension (PAH). We hope to demonstrate how this novel approach
to CPET interpretation, which includes a quantification of activity-related dyspnea and
evaluation of its underlying mechanisms, enhances our ability to meaningfully intervene
to improve quality of life in these pathologically-distinct conditions.
Keywords: exercise, dyspnea, pulmonary mechanics, chronic obstructive pulmonary disease, interstitial lung
disease, pulmonary vascular diseases
INTRODUCTION
Dyspnea and exercise intolerance are commonly the most troublesome symptoms reported by
patients with chronic pulmonary diseases and contribute significantly to poor quality of life.
Moreover, dyspnea, physical inactivity and reduced peak oxygen consumption (V˙O2) are closely
inter-related and have been shown to predict earlier mortality in various chronic pulmonary
diseases (Oga et al., 2003; Pinto-Plata et al., 2004; Waschki et al., 2011; Ley et al., 2016). Not
surprisingly, improving dyspnea and exercise tolerance are major goals in the management of
chronic lung diseases.
Exercise capacity cannot reliably be predicted in any individual based solely on careful clinical
assessment or resting pulmonary function tests (O’Donnell et al., 2001). Patients with chronic
dyspnea routinely avoid activities that provoke this unpleasant symptom and therefore, commonly
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underestimate (and under-report) true symptom severity
and its negative long-term impact on exercise capacity.
Cardiopulmonary exercise testing (CPET) alone provides
a rigorous evaluation of the interface between respiratory
impairment (caused by disease) and reduced exercise capacity in
an individual under measured physiological stress. It uniquely
permits an objective assessment of the integrated functions of
the neurosensory, metabolic, respiratory, cardiovascular, and
locomotor muscle systems to graded physical exertion.
A fact that has traditionally been overlooked in studies
of exercise physiology is that the proximate limitation of
exercise performance in chronic lung disease populations is
very often intolerable symptoms such as dyspnea, not critical
encroachment on physiological maxima of the cardiovascular
and respiratory systems (Killian et al., 1992; O’Donnell and
Webb, 1993; Hamilton et al., 1996). Accordingly, there is renewed
interest in elucidating the underlying mechanisms of exertional
dyspnea. Moreover, there is now broader acknowledgment
that measurements of exertional symptoms and non-invasive
dynamic respiratorymechanics are integral components of CPET
(ERS Task Force et al., 2007; O’Donnell et al., 2009; Guenette
et al., 2013; Puente-Maestu et al., 2016).
For the pulmonologist interested in evaluating the severity
of activity-related dyspnea and in discovering its cause(s) in
individual patients, we suggest a simple, ordered interrogation of
perceptual and physiological responses to incremental exercise.
These include: (1) perceptual responses: dyspnea (Borg) ratings
as a function of increasing work rate (WR) [and/or minute
ventilation (V˙E)]; (2) ventilatory control: V˙E-WR, V˙E-carbon
dioxide production (V˙CO2) ratio, O2 saturation, and partial
pressure of end-tidal carbon dioxide (PetCO2) as a function of
WR; (3) dynamic respiratory mechanics: change in inspiratory
capacity (IC), inspiratory reserve volume (IRV), tidal volume
(VT) and breathing frequency (f ), all as a function of increasing
WR (or V˙E); quantitative flow-volume loop analysis (mentioned
only briefly in the current review) and (4) metabolic and
cardiocirculatory responses: V˙O2-WR, V˙CO2-V˙O2 (“V-slope”
method to estimate the lactate threshold), heart rate (HR) and
O2 pulse as a function of V˙O2 (Weisman and Zeballos, 1994;
Johnson et al., 1999; Ofir et al., 2008a; Chin et al., 2013; Guenette
et al., 2014; Elbehairy et al., 2015a,b; Faisal et al., 2015, 2016).
Abbreviations: V˙A, Alveolar ventilation; V˙A/Q, Ventilation/perfusion; A-aPO2,
Alveolar-to-arterial oxygen tension gradient; V˙CO2, Carbon dioxide production;
COPD, Chronic obstructive pulmonary disease; CPET, Cardiopulmonary exercise
testing; DH, Dynamic hyperinflation; DLCO, Diffusing capacity of the lungs for
carbon monoxide; V˙E, Minute ventilation; EELV, End-expiratory lung volume;
EFL, Expiratory flow limitation; EILV, End-inspiratory lung volume; EMGdi,
Diaphragmatic electromyography; ERV, Expiratory reserve volume; f, Breathing
frequency; FEV1, Forced expired volume in one second; FVC, Forced vital
capacity; HR, Heart rate; IC, Inspiratory capacity; ILD, Interstitial lung disease;
IRV, Inspiratory reserve volume; LV, left ventricle; MVC, Maximal ventilatory
capacity; NMD, Neuromechanical dissociation; V˙O2, Oxygen consumption; PAP,
Pulmonary artery pressure; PaCO2 , partial pressure of arterial oxygen; PEEP,
Positive end-expiratory pressure; Pes, Esophageal pressure; PO2, Partial pressure
of oxygen; PVR, Pulmonary vascular resistance; RV, Residual volume; TLC, Total
lung capacity; VC, Vital capacity; VD, Dead space volume; VT, Tidal volume; WR,
Work Rate PAH: pulmonary arterial hypertension; PetCO2, partial pressure of
end-tidal carbon dioxide; SV, Stroke volume.
We begin by briefly reviewing the natural changes in
respiratory physiology that negatively impact exercise capacity
with advancing age, since the healthy elderly are the appropriate
reference population for most patients with chronic respiratory
conditions. We then describe the abnormal responses to exercise
in three separate lung disease categories (obstructive, restrictive
and pulmonary vascular diseases). In so doing, we uncover
common mechanisms of dyspnea and exercise intolerance across
these diverse diseases. Finally, we hope to demonstrate that
a simple systematic approach that emphasizes both perceptual
and physiological responses (ventilatory control and mechanics)
allows the clinician to develop a cogent physiological rationale
for effective treatment of dyspnea and exercise tolerance in these
common chronic respiratory diseases.
OLDER HEALTHY INDIVIDUALS
Respiratory Responses to Exercise in
Older Healthy Individuals
The healthy respiratory system admirably fulfills its primary
task of ensuring that alveolar ventilation (V˙A) is commensurate
with the increasing muscular metabolic demands of incremental
exercise, even at high intensities (West, 2004). Moreover, it
accomplishes this feat while maintaining arterial blood gas and
acid-base homeostasis and ensuringminimal perceived breathing
difficulty. Young, untrained adults can accomplish high peak
V˙E (e.g., 120 L/min) with little respiratory discomfort while
requiring only 5–7% of their total body V˙O2 (Aaron et al., 1992).
The work and O2 cost of breathing during exercise, and
attendant perceived breathing difficulty, are minimized in young
adults through several acute physiological adjustments. First, V˙E
is maintained close to V˙A during exercise because of enhanced
ventilation/perfusion (V˙A/Q) relationships, while increased VT
reduces the “wasted” fraction of the breath [physiological dead
space (VD)] (Johnson et al., 1994). Second, the behavior of
the operating lung volumes is carefully controlled to minimize
increases in elastic loading of the inspiratory muscles (Henke
et al., 1988). Thus, in young adults, end-expiratory lung volume
(EELV) reduction by expiratory muscle recruitment during
exercise allows VT expansion to about 50–60% of the vital
capacity (VC) by encroachment on both the expiratory and the
inspiratory reserve volumes (Henke et al., 1988). This helps
mitigate the increased elastic work associated with breathing
closer to total lung capacity (TLC). Finally, resistive work is
minimized despite high flow rates during exercise by intra-
and extra-thoracic airway dilatation (England and Bartlett, 1982;
Warren et al., 1984).
These adaptations in pulmonary gas exchange and dynamic
respiratory mechanics are variably attenuated with increasing
age. These aging effects include progressive reductions in
alveolar-capillary surface area for gas exchange, worsening of
V˙A/Q relationships, and smaller increases in VT during exercise
due to decreased chest wall compliance preventing normal
declines in physiological dead space (Ofir et al., 2008b; Faisal
et al., 2015). Submaximal V˙E is, therefore, increased at any given
V˙CO2, V˙O2 or WR, reflecting the higher physiological dead
space (Figure 1) (Faisal et al., 2015). The reduced efficiency in
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FIGURE 1 | Comparison of ventilation (A), ventilatory equivalent for carbon dioxide (V˙E/V˙CO2) (B), end-tidal CO2 (C), and arterial oxygen saturation (D), all plotted
against oxygen uptake, during incremental cycle exercise in healthy young and older adults. Values are mean ± SEM. *P < 0.05 healthy young versus older adults.
PETCO2, partial pressure of end-tidal carbon dioxide; SpO2, oxygen saturation by pulse oximetry. Reproduced with permission from the publisher (Faisal et al., 2015).
CO2 elimination also means that the central inspiratory drive to
breathe is increased at any given WR compared with younger
individuals (Dantzker and D’Alonzo, 1986; DeLorey and Babb,
1999; Prioux et al., 2000; Neder et al., 2003; Ofir et al., 2008b).
Age-related changes in the pulmonary connective tissue
matrix are associated with reduced static elastic recoil pressure
and driving pressure for expiratory flow (Frank et al., 1957;
Olafsson and Hyatt, 1969; D’Errico et al., 1989; Johnson et al.,
1994; Pride, 2005). Increased lung compliance and reduced
airway tethering, together with changes in the autonomic balance
of airway smooth muscle tone (possibly increased cholinergic
influences), predisposes the elderly to expiratory flow limitation
(EFL) (Turner et al., 1968; D’Errico et al., 1989; Johnson et al.,
1991, 1994; Verbeken et al., 1992; Wilkie et al., 2012). During
resting breathing, closing volume and the ratio of residual volume
(RV) to TLC are both increased (Mittman et al., 1965; Anthonisen
et al., 1969; Bode et al., 1976; McClaran et al., 1995). Resting IC
is also diminished compared with younger individuals due to
reduction in diaphragmatic strength with age, likely as a result
of muscle atrophy and the age-related decrease in fast twitch
fibers (Anthonisen et al., 1969; Tolep et al., 1995; Polkey et al.,
1997). These changes are amplified by the higher ventilatory
requirements of exercise, such that dynamic hyperinflation (DH);
the transient increase of EELV above the resting value, can occur
particularly at high V˙E in fit elderly individuals (DeLorey and
Babb, 1999; Ofir et al., 2008b; Faisal et al., 2015).
Inability to reduce EELV in the elderly means that elastic work
of breathing is increased and work sharing between expiratory
and inspiratory muscles is compromised (Ofir et al., 2008b;
Faisal et al., 2015). Moreover, the more rapid decline in dynamic
IRV and earlier attainment of a plateau in the VT/V˙E relation
have negative sensory consequences (DeLorey and Babb, 1999;
Ofir et al., 2008b; Faisal et al., 2015). The combination of
higher ventilatory demand and increased resistive and elastic
loading of the respiratory muscles means that the O2 cost of
breathing may represent as much as 13% of the total V˙O2
in healthy older individuals (Harms et al., 1997). Generally,
older more sedentary individuals avoid dyspnea provocation
simply by avoiding high intensity exercise; however, critical
respiratory mechanical constraints and attendant respiratory
discomfort are well documented in older elite athletes who are
determined to meet the challenge of exercising at high power
outputs (Dempsey et al., 1984; Johnson et al., 1991). The age-
related physiological derangements of pulmonary gas exchange
and respiratory mechanics outlined above are exaggerated in
patients in the early stages of various chronic lung diseases.
This underlines the importance of using age-matched controls in
studies of exercise pathophysiology in disease states.
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Cardiovascular Responses to Exercise in
Healthy Elderly
Age-related declines in peak V˙O2 are influenced by changes
in the cardio-circulatory system, which undergoes significant
structural changes during healthy aging (Arbab-Zadeh et al.,
2004; Fujimoto et al., 2012; Strait and Lakatta, 2012). While
global left ventricular (LV) systolic function and peak stroke
volume (SV) are largely unchanged (Forman et al., 1992; Lakatta,
2003; Strait and Lakatta, 2012; Bhella et al., 2014), peak cardiac
output falls by ∼25% between 20 and 80 years of age (Fleg et al.,
2005). Additionally, peak HR declines by 0.7 beats.min−1.year−1
(Tanaka et al., 2001) as a result of reduced beta(β)-adrenergic
responsiveness with advancing age, which is partially offset by
exercise-induced ventricular dilation (Filburn and Lakatta, 1984;
Fleg et al., 1994; Brubaker and Kitzman, 2011). Thus, reduced
HR and maldistributed cardiac output are responsible for the
cardiac contribution to age-related decline in peak V˙O2. Simply
speaking, the cardiac response of the aging individual during
exercise has been likened to that of a young person on β-blockers
(Cheitlin, 2003).
Age attenuates the normal increases in HR, LV ejection
fraction, and cardiac output observed during supine and upright
incremental exercise (Geokas et al., 1990; Stratton et al., 1994).
Aging hearts may utilize different mechanisms to increase
SV during exercise compared to younger ones. Exercising
elderly subjects try to maintain their SV via increases in end-
diastolic volume, i.e., through the Frank-Starling mechanism;
cardiac output may not be increased efficiently in subjects
not exhibiting this cardiac dilatation. In younger subjects,
SV is increased by a progressive decrease in end-systolic
volume and little change in end-diastolic volume, in other
words by an increase in the LV ejection fraction (Geokas
et al., 1990; Stratton et al., 1994). It is worth noting that age
does not alter the cardiac output–V˙O2 relationship; however,
for a given cardiac output, older subjects have decreased
blood flow to the exercising leg muscles (Betik and Hepple,
2008).
The lactate threshold declines with age (Neder et al.,
1999a; Pollock et al., 2015), though it increases with aging
when expressed as % peak V˙O2 (Iredale and Nimmo, 1997).
Decreases in the lactate threshold occur less rapidly during
aging than the observed decreases in V˙O2 (Posner et al.,
1987). These phenomena have been attributed to age-related
decrease in maximal V˙O2 (Reinhard et al., 1979; Cunningham
et al., 1985; Posner et al., 1987). The occurrence of the
lactate threshold at a higher percentage of maximum V˙O2
in older individuals (Iredale and Nimmo, 1997) may also be
attributed to decreased lactate production, improved clearance,
or both. Moreover, the β-adrenergic receptor system has a
significant effect on blood lactate concentration during exercise,
with β-adrenergic stimulation increasing lactate production
(Stainsby and Brooks, 1990). Thus, reduced β-adrenergic
receptor sensitivity in advanced age may decrease lactate
production, altering the balance between production and
removal. Alteration in muscle fiber composition and recruitment
may also play a role in circulating blood lactate levels (Spirduso,
1995).
CHRONIC OBSTRUCTIVE PULMONARY
DISEASE
It is generally believed that smokers with unremarkable
spirometric abnormalities, who are free of troublesome
respiratory symptoms, need no treatment beyond the imperative
of a smoking cessation intervention. However, this view is rapidly
changing. Recent epidemiological studies have confirmed that
activity-related dyspnea, activity restriction, poor quality of life,
and increased risk of mortality are present in many symptomatic
smokers with only minor spirometric abnormalities (Furlanetto
et al., 2014; Regan et al., 2015; Woodruff et al., 2016). In
this context, we now have a much better understanding of
the heterogeneous nature of the physiological impairment in
smokers with minor airway obstruction (Ofir et al., 2008a;
Deesomchok et al., 2010; Chin et al., 2013; Guenette et al., 2014;
Elbehairy et al., 2015a,b, 2016). Established abnormalities in
mild COPD include: increased alveolar-to-arterial O2 tension
gradient (A-aPO2) during resting breathing (Barbera et al., 1991;
Rodriguez-Roisin et al., 2009; Elbehairy et al., 2015a); reduced
diffusing capacity of the lungs for carbon monoxide (DLCO)
and reduced transfer factor (Kirby et al., 2013; Harvey et al.,
2015); increased peripheral airways resistance (Hogg et al., 2004;
McDonough et al., 2011); maldistribution of alveolar ventilation
(Buist, 1973); EFL, pulmonary gas trapping (increased ratio of
RV to TLC) and reduced IC (Ofir et al., 2008a; Chin et al., 2013;
Guenette et al., 2014; Elbehairy et al., 2015a,b).
Similar derangements of pulmonary gas exchange, dynamic
respiratory mechanics and muscle function are seen in more
advanced COPD. They differ from those changes observed in
mild COPD in that they are more pronounced and occur at
significantly lower V˙E and WR (O’Donnell et al., 2012; Neder
et al., 2015; Faisal et al., 2016).
Increased Inspiratory Neural Drive during
Exercise in COPD: Increased
Chemostimulation
The physiological adjustments that optimize pulmonary gas
exchange and mechanics in youth and are attenuated by
natural aging are further eroded by tobacco-related lung injury.
Normally, the ventilatory response to exercise is coupled to
metabolic demand (increasing V˙CO2) throughout incremental
exercise (i.e., V˙E/V˙CO2 = 1/[PaCO2×(1 − VD/VT)]). In other
words, the higher the V˙E/V˙CO2 (i.e., less “efficient” ventilation),
the lower the level at which PaCO2 is regulated (i.e., CO2set-
point) and the greater the fraction of the breath that is wasted
as VD (Wasserman et al., 1999). Poor ventilatory efficiency
is a key physiological abnormality in symptomatic smokers
with largely preserved forced expiratory volume in one second
(FEV1) (Ofir et al., 2008a; Chin et al., 2013; Guenette et al.,
2014; O’Donnell et al., 2014a; Neder et al., 2015; Elbehairy
et al., 2015a,b). The physiological basis for this seems to stem
from an enlarged VD per se, rather than a small VT or a
low PaCO2 set point (Elbehairy et al., 2015a). In fact, added
external VD predictably increases V˙E/V˙CO2 in these patients
(Chin et al., 2013). Additionally, reduced pulmonary perfusion
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and resultant areas of high V˙A/Q mean that less CO2 is
presented to the alveoli for removal with net dilution of PetCO2
from the expired VT (Hansen et al., 2007; Elbehairy et al.,
2015a). Regardless of the mechanism(s), the excessive ventilatory
response erodes mechanical reserves, thereby contributing to
exertional dyspnea and exercise intolerance (Ofir et al., 2008a;
Chin et al., 2013; Guenette et al., 2014; Elbehairy et al.,
2015a,b).
During the challenge of incremental exercise, the dominant
abnormalities in mild COPD include (Figure 2): (1) increased
chemostimulation of respiratory centers secondary to the effects
of high physiological dead space compared with healthy controls,
which is indirectly reflected by higher V˙E/V˙CO2 nadir and
steeper V˙E-V˙CO2 slope; and (2) increased airways resistance
and DH due to the combined effects of peripheral airway
disease (EFL), increased ventilatory demand and central motor
command output (Ofir et al., 2008a; Chin et al., 2013; Guenette
et al., 2014; Elbehairy et al., 2015a,b). These combinations of
increased mechanical loading of the muscles, dynamic functional
muscle weakness (due to geometric muscle fiber shortening),
and increased velocity of contraction means that efferent motor
output to the respiratory muscles from cortical centers in the
brain must increase to maintain adequate force generation
(Pride and Macklem, 1986). Reduced IC during exercise (due
to increased EELV) coupled with higher inspiratory neural
drive (due to inefficient pulmonary gas exchange and increased
mechanical loading) result in critical mechanical constraints and
higher exertional dyspnea ratings earlier in exercise in mild
COPD than in age-matched healthy controls (see also next
section) (Ofir et al., 2008a; Chin et al., 2013; Guenette et al., 2014;
Elbehairy et al., 2015a,b).
In moderate-to-severe COPD, the progressively increasing
intrinsic mechanical loading of the functionally weakened
respiratory muscles requires augmented increases in efferent
motor drive (from the motor cortex) to achieve a given force
generation (Figure 3) (Gandevia et al., 1981; Gandevia, 1982;
Turner, 1991; Faisal et al., 2016). Additionally, reflex stimulation
of the central and peripheral chemoreceptors occurs as a result
of: (1) V˙A/Q abnormalities (decreased ventilatory efficiency,
high V˙A/Q lung units, and increased physiological dead space)
(Caviedes et al., 2012; Neder et al., 2015); (2) critical arterial
O2 desaturation (low V˙A/Q lung units and reduced systemic
mixed venous O2 in the blood) (Andrianopoulos et al., 2014;
Moreira et al., 2014); and (3) increased acid-base disturbances
FIGURE 2 | Proposed panel displays for interpretation of key perceptual (A), ventilatory, and dynamic respiratory mechanical responses (B–I) to incremental
exercise test in patients with chronic respiratory diseases. Data showing these responses in patients with mild COPD and age-matched healthy controls. Values are
mean ± SEM. *p < 0.05 mild COPD vs. healthy controls at rest, at standardized work rates or at peak exercise. VE/VCO2, ventilatory equivalent for carbon dioxide;
IC, inspiratory capacity; IRV, inspiratory reserve volume; Fb, breathing frequency; PETCO2, partial pressure of end-tidal carbon dioxide; SpO2, oxygen saturation by
pulse oximetry. Reproduced with permission from the publisher (Chin et al., 2013).
Frontiers in Physiology | www.frontiersin.org 5 February 2017 | Volume 8 | Article 82
O’Donnell et al. Exercise Testing for Lung Diseases
FIGURE 3 | Dyspnea intensity (Borg units) (A), diaphragm electromyography (EMGdi) (B) and selected ventilatory and indirect gas exchange responses (C–I) to
incremental cycle exercise test in patients with moderate COPD and age-matched healthy controls. Values are mean ± SEM. Square symbols represent tidal
volume-ventilation inflection points. *p < 0.05 for COPD vs. control subjects at rest, at standardized work rates, at peak exercise, or at the tidal volume-ventilation
inflection points. EMGdi/EMGdi,max, an index of inspiratory neural drive to the crural diaphragm; V˙E, minute ventilation; VE/VCO2, ventilatory equivalent for carbon
dioxide; PETCO2, partial pressure of end-tidal carbon dioxide; SpO2, oxygen saturation by pulse oximetry; VT, tidal volume; Fb, breathing frequency; IRV, inspiratory
reserve volume; TLC, total lung capacity. Reproduced with permission from the publisher (Faisal et al., 2016).
(e.g., early metabolic acidosis) due to deconditioning or impaired
cardiac function (Patessio et al., 1993; Pleguezuelos et al.,
2016). In advanced COPD, alveolar hypoventilation with CO2
retention can occur, reflecting critical mechanical limitation and
respiratory muscle dysfunction, particularly in the setting of high
VD and restricted VT expansion (see below) (O’Donnell et al.,
2002, 2014a). Finally, the negative haemodynamic consequences
of combined resting and dynamic hyperinflation may reduce
cardiac output, and thus O2 delivery to the contracting
peripheral muscles, amplifyingmetabolic acidosis and ventilatory
stimulation (Chiappa et al., 2008; Laveneziana et al., 2009, 2011;
Vasilopoulou et al., 2012).
As previously reported, VD/VT was found to be higher in mild
COPD patients compared with healthy controls due to higher
VD rather than smaller VT (Elbehairy et al., 2015a). Similar to
heart failure (Woods et al., 2010), VD/VT worsens in tandemwith
COPD severity (O’Donnell et al., 2014b). Interestingly, while the
most commonly-used parameter of ventilatory efficiency (V˙E-
V˙CO2 slope) increases from mild to severe heart failure (Sue,
2011); it decreases frommild to (very) severe COPD (Neder et al.,
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2015). This seemingly paradoxical finding is explained by the
worsening mechanical constraints on increasing ventilation in
COPD (Figure 4) (O’Donnell et al., 2012, 2014b), which in end-
stage disease can lead to hypercapnia at end-exercise (O’Donnell
et al., 2002; Poon et al., 2015). Thus, caution is necessary when
using the V˙E-V˙CO2 relationship to interpret the trajectory of
increases in physiological dead space in patients with limiting
mechanical constraints.
Abnormal Dynamic Respiratory Mechanics
during Exercise in COPD
Increased respiratory motor drive and respiratory muscle effort
occur in COPD due to increased elastic loading [including
increased inspiratory threshold loading due to the effect of
intrinsic positive end-expiratory pressure (PEEP)], decreased
dynamic lung compliance, and increased resistive loading of the
respiratory muscles (Potter et al., 1971; Dodd et al., 1984; Jolley
et al., 2015; Faisal et al., 2016). IC is a useful non-invasive marker
of dynamic respiratory mechanics in pulmonary diseases, as it
indicates how close the patient is breathing to TLC. In both mild
and advanced COPD, critical dynamic mechanical constraints
are indicated by DH and by premature encroachment of end-
inspiratory lung volume (EILV) on TLC, i.e., the attainment
of a critically reduced IRV (Figures 2, 3) (Ofir et al., 2008a;
O’Donnell et al., 2011, 2012; Chin et al., 2013; Guenette et al.,
2013, 2014; Elbehairy et al., 2015a,b; Faisal et al., 2016). Thus,
VT becomes positioned close to TLC and the upper reaches of
the S-shaped pressure-volume relation of the relaxed respiratory
system, where compliance is decreased and the inspiratory
muscles are functionally weakened. This explains the blunted VT
response and relative tachypnea in COPD compared with healthy
controls (Figures 2, 3) (Chin et al., 2013; Faisal et al., 2016). This
increased breathing frequency and velocity of shortening of the
inspiratory muscles causes further functional weakness of those
muscles (Leblanc et al., 1988).
Expiratory muscle activity is relatively increased in COPD, but
fails to prevent DH (Ciavaglia et al., 2014; Laveneziana et al.,
2014). In fact, excessive expiratory muscle recruitment may have
deleterious hemodynamic effects, which further compromise
exercise performance (Potter et al., 1971; Kyroussis et al.,
2000). Evidence that respiratory muscle fatigue is present at
the limits of tolerance in advanced COPD is inconclusive, but
some degree of dynamic functional weakness of the overloaded
inspiratory muscles is measurable in such patients (Mador
et al., 2000); however, overt “static” (resting) inspiratory muscle
weakness is reported in a subset of advanced COPD patients
and is multifactorial (Gosselink et al., 1996; Charususin et al.,
2016). In this group, it is anticipated that further dynamic
respiratory muscle weakness will occur at higher ventilation
during progressive exercise (Rodrigues et al., in press).
FIGURE 4 | Tidal volume (VT) (A), breathing frequency (Fb) (B), dynamic inspiratory capacity (IC) (C), and inspiratory reserve volume (IRV) (D) are shown plotted
against minute ventilation (V˙E) in four disease severity quartiles based on FEV1 %predicted during constant work rate exercise in patients with COPD. Note the clear
inflection (plateau) in the VT/V˙E relationship which coincides with a simultaneous inflection in the IRV. After this point, further increases in VE are accomplished by
accelerating Fb. Data plotted are mean values at steady-state rest, isotime (i.e., 2, 4 min), the VT/V˙E inflection point, and peak exercise. VC, vital capacity; TLC, total
lung capacity. Reproduced with permission from the publisher (O’Donnell et al., 2012).
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Cardiovascular Responses to Exercise in
COPD
Despite the fact that cardio-circulatory abnormalities are well
documented in patients in the early stages of COPD, as tobacco
smoking is a common risk factor (Sin et al., 2005; Malerba
et al., 2011), crude non-invasive assessment of cardiac function
during exercise may not be different from control subjects. For
example, there is relatively greater variability in HR responses
to incremental exercise in mild COPD patients compared with
age-matched controls. HR at submaximal WR and V˙O2 is often
higher in patients with mild COPD compared with age-matched
controls (Chin et al., 2013; Elbehairy et al., 2015a,b). However,
this finding alone is not diagnostic for cardiac abnormality. On
the other hand, O2 pulse (a surrogate for SV during exercise)
and HR reserve (predicted maximal HR minus peak HR) were
not different during exercise in a group of patients with mild-
moderate COPD (FEV1 62% predicted) and patients with more
preserved FEV1 (94% predicted) compared with control subjects
(Wang et al., 2011; Elbehairy et al., 2015a). Use of these crude
exercise measures might not, therefore, be conclusive when
assessing early cardiovascular changes in patients with mild
COPD.
Patients with mild COPD are unlikely to develop pulmonary
arterial hypertension (PAH) at rest, though one report suggests
that it presented in up to 17% of their sample (Gupta et al.,
2011). These patients would also have an increased likelihood of
developing PAH during exercise, as supported by Portillo et al.
who showed an abnormal increase of pulmonary artery pressure
(PAP) during exercise in 70% of patients with GOLD grade 2
COPD (Portillo et al., 2015). Patients with exercise-induced PAH
are also more prone to develop resting PAH in subsequent years
(Kessler et al., 2001). To the best of our knowledge, there are
no studies of exercise-induced PAH in GOLD grade 1 COPD
patients.
The effect of more severe COPD on cardiac performance
during exercise is complex, multifactorial, difficult to assess
using HR responses during CPET and generally needs additional
testing. Severe lung hyperinflation and excessive expiratory
muscle recruitment can impair venous return and reduce
right ventricular preload (Aliverti and Macklem, 2001). The
large intrathoracic pressure swings generated during exercise
to overcome increased elastic and resistive loads may result in
LV dysfunction (increased LV afterload), especially in patients
with cardiac comorbidity. Additionally, several studies have
demonstrated increased pulmonary vascular resistance (PVR)
during exercise in moderate-severe COPD (Light et al., 1984;
Mahler et al., 1984; Magee et al., 1988; Oswald-Mammosser
et al., 1991), which results from emphysematous vascular
destruction in conjunction with reduced volume or compliance
of the pulmonary vascular bed and, in some cases, from
vasoconstriction due to regional alveolar hypoxemia (Light
et al., 1984; Mahler et al., 1984; Magee et al., 1988; Agusti
et al., 1990; Oswald-Mammosser et al., 1991). In some
cases, mechanical compression of intra-alveolar vessels may
also occur as a result of regional DH. Finally, severe lung
hyperinflation can mechanically impede cardiac output (e.g.,
tamponade) in very advanced COPD (Stone et al., 2016; Watz,
2016).
PAP and right ventricular afterload are generally much higher
in moderate-severe COPD than in health at a given cardiac
output (Matthay et al., 1980; Agusti et al., 1990). Right ventricular
afterload during exercise is increased in COPD because of the
increased PVR associated with breathing at lung volumes close
to TLC, and earlier studies showed failure to increase right
ventricular ejection fraction despite a rise in right ventricular
end-diastolic pressure (Matthay et al., 1980; Magee et al., 1988;
Agusti et al., 1990; Vizza et al., 1998). LV ejection fraction is
generally preserved in COPD in the absence of concomitant
ischemic heart disease or hypertension (Morrison et al., 1987;
Vizza et al., 1998); however, LV diastolic function may be
impaired because of ventricular interdependence, i.e., increased
tension or displacement of the right ventricle as a result of
increased PVR, which may impede LV diastolic filling (Morrison
et al., 1987; Vizza et al., 1998). Cardiac output has been found
to increase normally with V˙O2 during submaximal exercise in
COPD, despite the increased PVR, but peak cardiac output (and
V˙O2) reaches lower values than in health (Mahler et al., 1984;
Montes de Oca et al., 1996). This maintained cardiac output
profile is attributable to decreased SV, and correspondingly
increased HR, at a given V˙O2 in COPD patients compared with
healthy individuals (Mahler et al., 1984).
Exertional Dyspnea in COPD
Exercise performance in COPD is primarily limited by
ventilatory factors and accompanying intolerable respiratory
discomfort in the majority of patients with more advanced
COPD. Progressive reduction of resting IC (as resting lung
hyperinflation increases) with disease progression helps explain
the diminishing operating limits for VT expansion and
progressively earlier attainment of a minimal IRV during exercise
(Figure 5) (O’Donnell et al., 2012). The point at which VT
reaches a critical minimal IRV is important during exercise.
This is where the disparity between increasing inspiratory neural
drive and the muscular/mechanical response of the respiratory
system abruptly widens [i.e., where neuromechanical dissociation
(NMD) begins] and marks the threshold beyond which dyspnea
intensity rises sharply to intolerable levels (O’Donnell et al., 2004,
2006, 2012). The hypothesis that activity-related dyspnea and
exercise intolerance are closely related to increased inspiratory
neural drive and NMD in COPD is supported by studies showing
that bronchodilator therapy, which improves dynamicmechanics
(increases resting IC), delays mechanical limitation and partially
restores neuromechanical coupling, delays the dyspnea threshold
and prolongs exercise endurance time (O’Donnell et al., 2004,
2006). Additionally, interventions that directly or indirectly
reduce inspiratory neural drive [e.g., supplemental oxygen
(O’Donnell et al., 1997, 2001; Somfay et al., 2001), opiates
(Mahler et al., 2009; Jensen et al., 2012; Johnson et al., 2013;
Rocker et al., 2013; Ekström et al., 2015), and exercise training
(Carrieri-Kohlman et al., 1996; Wadell et al., 2013)] can further
improve dyspnea and exercise tolerance.
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FIGURE 5 | Inter-relationships are shown between exertional dyspnea intensity, ventilation (V˙E) (A) and the VT/IC ratio (B) in four disease severity quartiles
based on FEV1 %predicted during constant work rate exercise in COPD. After the VT/IC ratio plateaus (i.e., the VT inflection point), dyspnea rises steeply to
intolerable levels. There is a progressive separation of dyspnea/VV˙E plots with worsening quartile. Data plotted are mean values at steady-state rest, isotime (i.e., 2, 4
min), the VT/V˙E inflection point, and peak exercise. IC, inspiratory capacity, VT, tidal volume. Reproduced with permission from the publisher (O’Donnell et al., 2012).
BRONCHIAL ASTHMA
We focused in our review on chronic respiratory diseases in
which functional consequences are largely non-reversible; we
provide only a brief outline of the main pathophysiological
mechanisms of exercise intolerance in patients with bronchial
asthma. Asthma is a heterogeneous airway inflammatory disease
characterized by EFL which is largely or fully reversed either
spontaneously or after treatment (GINA, 2016). Patients with
asthma respond variably to the stress of exercise depending
on the degree of obstruction and bronchodilator reversibility.
Furthermore, some atypical causes of exertional dyspnea are
more common in asthma than other chronic respiratory diseases,
including psychogenic hyperventilation (Ritz et al., 2008),
dysfunctional breathing (Agache et al., 2012) and paradoxical
vocal cord motion (Low et al., 2017). Thus, exercise responses
in asthma characteristically vary among patients and in a given
patient on different days (Del Giacco et al., 2015).
Increased Inspiratory Neural Drive during
Exercise in Asthma: Increased
Chemostimulation
The presence of recurrent bronchoconstriction (or persistent
airflow obstruction) in some patients with bronchial asthma is
associated with resting and exertional dyspnea which contributes
to a sedentary lifestyle (Ford, 2003; Verlaet et al., 2013; Damera
and Panettieri, 2014). Excessive exercise ventilation due to an
increased chemostimulation (early metabolic acidosis) (Neder
et al., 1999b) and increased wasted ventilation (Anderson et al.,
1972) have been reported and might accelerate the rate of airway
dehydration, a potent trigger for mediator release and exercise-
induced bronchoconstriction in some patients (Parsons et al.,
2013). Bronchoconstriction may cause an uneven distribution
of ventilation relative to perfusion with consequent widening
of the A-aPO2 (Wagner et al., 1987). However, most studies
reported that, on average, asthmatic patients did not present
with substantial hypoxemia or hypercapnia (Feisal and Fuleihan,
1979; Graff-Lonnevig et al., 1980; Wagner et al., 1987). Yet,
an influential study (Haverkamp et al., 2005) reported that a
sizeable fraction of habitually active asthmatic subjects (∼35%)
developed gas exchange abnormalities during exercise, which
was associated with more extensive EFL, DH and increased
airway resistance. Of note, post-exercise sputum histamine
was correlated with measures of gas exchange inefficiency
(Haverkamp et al., 2005). These data suggest that release
of airway-related mediators worsened ventilation distribution
during exercise (Haverkamp et al., 2005). In fact, a more pro-
active treatment of airway inflammation with higher doses of
inhaled steroids was associated with improved exertional A-aPO2
in mild tomoderate asthma (Haverkamp et al., 2007). Thus, some
patients with apparently well-controlled asthma may present
with subtle physiological abnormalities which are amplified by
the stress of exercise (Feisal and Fuleihan, 1979; Wagner et al.,
1996; O’Donnell and Laveneziana, 2007; Rossman et al., 2014; Del
Giacco et al., 2015). In patients with difficult to control asthma,
CPET has been found useful to ascertain whether or not there is
a “respiratory” cause of exercise limitation, a finding that impacts
on disease management (McNicholl et al., 2011).
Abnormal Dynamic Respiratory Mechanics
during Exercise in Asthma
Gas trapping and lung hyperinflation might occur in patients
with bronchial asthma depending on the prevailing level of
airway narrowing (Vermeulen et al., 2016). In this context,
the sub-group of patients with “fixed,” poorly-reversible airflow
obstruction may present with mechanical-ventilatory constraints
and exertional dyspnea akin to COPD (O’Donnell and
Laveneziana, 2007). At the other end of the functional
spectrum, asthmatic adults (Rossman et al., 2014) and children
(Santuz et al., 1997) with largely preserved FEV1 may present
with mechanical and pulmonary gas exchange responses
indistinguishable to sedentary controls. Interestingly, however,
there is some evidence that patients with apparently-preserved
lung function may develop significant inspiratory constraints
secondary to higher operating lung volumes. As expected, these
abnormalities were associated with lower exercise endurance and
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higher exertional dyspnea (Laveneziana et al., 2013b). These
patients may present with tidal EFL leading to DH and a
critically-low IRV (Kosmas et al., 2004). Similar to COPD, a
VT inflection point marked a change in dyspnea quality from
“my breathing requires more effort” to “I cannot take a deep
breath in,” thereby indicating that the inspiratory constraints are
centrally perceived as an abnormal response (Kosmas et al., 2004;
Laveneziana et al., 2013b; Vermeulen et al., 2016).
The reported variability in the presence and extent of
mechanical and gas exchange abnormalities in asthma might
be partially related to the complexities involved in the control
of bronchomotor tone during exercise (Pellegrino et al., 1998;
Crimi et al., 2002; Rossman et al., 2014). Thus, increases in
operating lung volumes, if associated with increases in VT,
are expected to dilate the airways due to the augmented
radial traction (Pellegrino et al., 1998). In fact, airway caliber
has been found to fluctuate inversely with decreased and
increased work load in asthmatics (Crimi et al., 2002). These
findings raised the hypothesis that stretching of airway smooth
muscle (ASM) might convey an important influence on airway
function during exercise in these patients (Rossman et al.,
2014). Recent evidence, however, demonstrates that the influence
of lung stretching on ASM contractile activity is dynamically
modulated by other potent physiological mechanisms, including
vagally-mediated neuromuscular reflexes, parasympathetic tone,
sympathetic excitation/circulating catecholamines and release
of airway-derived mediators (Klansky et al., 2016). Increases
in EELV might also have some beneficial effects in increasing
airway diameter and/or reducing airway closure, due to airways-
lung parenchyma interdependence (Brown et al., 2001). These
sources of variability would add to the large circadian fluctuations
in airway inflammation (Durrington et al., 2014) and further
increase the heterogeneity of exercise responses in individual
patients over time (Del Giacco et al., 2015).
RESTRICTIVE LUNG DISEASES
Restrictive lung disorders (e.g., lung parenchymal diseases,
neuromuscular disorders, chest wall restriction, and pulmonary
resection) are characterized by an inability to expand VT
appropriately during the increasedmetabolic demand of exercise.
Here, we focus solely on the interstitial lung diseases (ILD).
Exercise intolerance is multifactorial in ILD, but intolerable
exertional symptoms, increased central inspiratory neural drive
(relative to maximum), and abnormal cardiac function, in
varying combinations, are important contributors (Krishnan and
Marciniuk, 2002).
The pathophysiological hallmark of ILD is reduced static
lung compliance (i.e., increased lung elastic recoil), which
simultaneously restricts lung volume expansion and increases the
driving pressure for expiratory airflow; thus, TLC, VC, and IC
are reduced while the ratio of FEV1/FVC is usually increased
(Parker et al., 2011). At rest, arterial blood gases may appear
normal or reveal mild hypoxemia and a compensated respiratory
alkalosis (American Thoracic Society, 2000). Disruption of the
pulmonary microvasculature and the alveolar-capillary interface
in ILD causes impaired gas exchange (i.e., decreased arterial O2
saturation, widened A-aPO2, and decreased DLCO) (American
Thoracic Society, 2000; Egan et al., 2005; Holland et al., 2008;
Parker et al., 2011; Cortes-Telles et al., 2014). At rest, the
increased ventilatory demand secondary to increased V˙A/Q
abnormalities, coupled with increased elastic loading of the
inspiratory muscles, can result in an increased work and O2
cost of breathing (American Thoracic Society, 2000; Faisal et al.,
2016).
Increased Inspiratory Neural Drive during
Exercise in ILD: Increased
Chemostimulation
Similar to COPD, central inspiratory neural drive to breathe is
higher when metabolic and ventilatory demand acutely increase
during exercise in patients with ILD compared with healthy
controls at any given work rate (Faisal et al., 2016) (Figure 6).
This reflects (in highly variable combinations) the increased
chemostimulation of central bulbo-pontine respiratory control
centers and the increased efferent (cortical) motor output as
a result of increased elastic loading of the respiratory muscles
(Nishimura et al., 1989).
As discussed in COPD, increased chemostimulation in ILD
similarly results from the effects of high V˙E/V˙CO2: reduced
efficiency of CO2 elimination occurs as a result of increased
wasted ventilation and/or relative alveolar hyperventilation due
to changes in the CO2 set-point (Figure 6) (O’Donnell et al.,
2007; Faisal et al., 2016). A key finding in fibrosing ILD is arterial
hypoxemia with widened A-aPO2 during exercise (Hamer, 1964;
Weitzenblum et al., 1983; Agusti et al., 1991; Hughes et al., 1991),
which can occur in early stages of the disease, even before resting
pulmonary function tests show overt impairment in DLCO and
lung mechanics (Johnson et al., 1960; Keogh et al., 1984).
The mechanisms of arterial O2 desaturation with exercise
include: inter- and intra-regional V˙A/Q inequalities in the
lungs, increased perfusion of units with low V˙A/Q with poorly
oxygenated mixed venous blood, diffusion disequilibrium with
decreased pulmonary capillary transit time, and, in some
individuals, increased intra-cardiac and intra-pulmonary right-
to-left shunting (Hamer, 1964; Weitzenblum et al., 1983; Agusti
et al., 1991; Hughes et al., 1991). Alveolar hyperventilation
in response to hypoxemia is associated with low PaCO2 with
a concomitant increase in PAO2, which further contributes
to widen exertional A-aPO2 (Risk et al., 1984). Alveolar
hypoventilation is not commonly reported during exercise, even
in advanced ILD, but severe VT restriction in the setting of
a fixed high VD can potentially cause CO2 retention in end-
stage disease (Javaheri and Sicilian, 1992). Correlations have been
found between the low resting DLCO and arterial hypoxemia
during exercise (Agusti et al., 1991), but there is considerable
overlap in this relationship, particularly in patients with mild to
moderate disease.
Additional sources of ventilatory stimulation in ILD may
include: altered reflex afferent activation of vagal receptors in the
lung parenchyma and airways (Paintal, 1969), early metabolic
acidosis due to deconditioning, and increased peripheral muscle
ergo-receptor activation (Hansen and Wasserman, 1996). As in
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FIGURE 6 | Dyspnea intensity (Borg units) (A), diaphragm electromyography (EMGdi) (B), and selected ventilatory and indirect gas exchange responses (C–I) to
incremental cycle exercise test in patients with interstitial lung disease (ILD) and age-matched healthy controls. Values are mean ± SEM. Square symbols represent
tidal volume-ventilation inflection points. *p < 0.05 for ILD vs. control subjects at rest, at standardized work rates, at peak exercise, or at the tidal volume-ventilation
inflection points. EMGdi/EMGdi,max, an index of inspiratory neural drive to the crural diaphragm; V˙E, minute ventilation; V˙E/V˙CO2, ventilator equivalent for carbon
dioxide; PETCO2, partial pressure of end-tidal carbon dioxide; SpO2, oxygen saturation by pulse oximetry; VT, tidal volume; Fb, breathing frequency; IRV, inspiratory
reserve volume; TLC, total lung capacity. Reproduced with permission from the publisher (Faisal et al., 2016).
COPD, additional ventilatory stimulation may arise in some
individuals due to comorbidities or complications, such as
obesity (i.e., increased metabolic loading), PAH, emphysema,
and cardio-circulatory disease (American Thoracic Society, 2000;
Parker et al., 2011; Faisal et al., 2016).
Abnormal Dynamic Respiratory Mechanics
during Exercise in ILD
During exercise, patients with ILD experience dynamic restrictive
mechanical constraints, which, as already seen in COPD, are
reflected in high VT/IC ratios and an early plateau of the
VT response as it reaches the critical minimal IRV earlier in
exercise compared with healthy individuals (Figure 6) (Faisal
et al., 2016). As in COPD, low VT precludes a normal decrement
in VD/VT ratio, worsening ventilatory inefficiency and increasing
inspiratory neural drive. This leaves tachypnea as the only
available option to respond to the higher drive (Javaheri and
Sicilian, 1992). This rapid and shallow pattern of breathing helps
attenuate the effects of increased elastic work of breathing and
the attendant respiratory discomfort; however, as ventilation
increases during exercise, the work of breathing increases
dramatically in order to overcome the high elastic loads of the
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stiff lungs and chest wall while breathing close to the reduced
TLC (O’Donnell et al., 2000). Moreover, the increased velocity
of shortening of the inspiratory muscles results in dynamic
functional inspiratory muscle weakness. Consequently, in most
instances, exercise intolerance in ILD is explained by true
ventilatory limitation and associated severe dyspnea (Kabitz et al.,
2006; Holland, 2010; Walterspacher et al., 2013; Panagiotou et al.,
2016).
In ILD, the pressure-volume relationship of the entire
respiratory system is contracted along its volume axis, but retains
its S-shape. The resting IC and IRV are usually diminished.
With exercise, EILV encroaches further on the upper non-linear
extreme of the pressure-volume relationship “beyond the S-
bend,” where there is significant elastic loading (Parker et al.,
2011). VT reaches a plateau at 50–60% of the reduced VC (or
∼ 70% of IC) early in exercise: minimal dynamic IRV and
the VT plateau are reached together with a step increase in
breathing frequency (Faisal et al., 2016). A few studies report
that IC remains largely unaltered throughout exercise, reflecting
a diminished expiratory reserve volume (ERV) and a reduced
ability to decrease EELV (Marciniuk et al., 1994; O’Donnell et al.,
1998). However, EFL has been described in some patients with
ILD and may reflect co-existent airway obstruction as a result of
smoking or actual airway involvement as part of the interstitial
disease process (e.g., hypersensitivity pneumonitis) (Jones and
Rebuck, 1979; Marciniuk et al., 1994). Interestingly, the presence
of EFL in ILD was associated with worsening dyspnea compared
with those with ILD who had normal airway function (Marciniuk
et al., 1994).
Inspiratory muscle function is often relatively preserved in
patients with ILD, reflecting the training effects of intrinsic
mechanical loading and the mechanical advantage of the
inspiratory muscles at the lower than normal operating lung
volumes (DeTroyer and Yernault, 1980; O’Donnell et al., 1998).
However, in some individuals, involvement of these muscles in
the underlying systemic inflammatory disease process, the effects
of cachexia, high dose oral steroids, malnutrition, electrolytic
disturbances, and/or global skeletal muscle deconditioning may
have a deleterious impact on function (Baydur et al., 2001; Kabitz
et al., 2006; Panagiotou et al., 2016).
Cardiovascular Responses to Exercise in
ILD
The characteristic cardiac abnormality in ILD is increased
PVR with consequent right ventricular hypertrophy ultimately
leading to corpulmonale during the terminal phase of the illness
(Weitzenblum et al., 1983; Sturani et al., 1986). LV ejection
fraction and systolic pressures are usually preserved, as are
pulmonary artery occlusion pressures (Lupi-Herrera et al., 1985;
Bush and Busst, 1988). Cardiac output is usually normal at
rest and during low levels of exercise in ILD, but the rate of
rise of cardiac output is diminished at higher work rates, due
in part to increased PVR (Lupi-Herrera et al., 1985; Bush and
Busst, 1988). PAP is high at rest and further increases during
exercise in the majority of patients with ILD (Hawrylkiewicz
et al., 1982; Weitzenblum et al., 1983; Jezek et al., 1985). Values
for PAP of ∼ 40 mmHg are not unusual, even in moderate ILD
during minimal activity. High levels of PAP are required during
exercise to maintain cardiac output when PVR is increased; PAP
is often double the normal value or higher (Weitzenblum et al.,
1983; Sturani et al., 1986). Obliteration of the vascular bed by
progressive parenchymal fibrosis is the main explanation for the
reduced vascular bed and the increased PVR in ILD (Enson
et al., 1975). Other factors contributing to the increased PVR are
hypoxic vasoconstriction and reduced lung volume.
HR responses to incremental exercise in ILD are variable.
HR at submaximal work rates is often higher than normal
(Widimsky et al., 1977; Baughman et al., 1984), reflecting
the relatively reduced SV and greater sympathetic stimulation
secondary to hypoxemia. Maximal HR, however, is generally
diminished, and there is adequate cardiac reserve at exercise
termination (Faisal et al., 2016). Diminished cardiac reserve
may become evident in patients with cardiac involvement in
the disease process (i.e., sarcoidosis, Eklund et al., 1989) or in
patients with additional extensive pulmonary vascular disease
(i.e., scleroderma, Guttadauria et al., 1979). As mentioned in the
COPD section, traditional assessments of cardiac function during
exercise based mainly on HR measurement are often relatively
insensitive.
Exertional Dyspnea in ILD
Increasing dyspnea intensity during CPET correlates well
with increasing amplitude of the inspiratory neural drive to
the diaphragm, the increasing esophageal pressure relative to
maximum, and the increasing VT/IC ratio (a measure of
prevailing mechanical constraints) in ILD (Figure 7) (O’Donnell
et al., 1998; Faisal et al., 2016). Thus, as in COPD, dyspnea
rises as a function of the increasing fractional inspiratory
neural drive to the inspiratory muscles, increased contractile
respiratory muscle effort, and intrinsic restriction of appropriate
VT expansion (Faisal et al., 2016). Similarly, interventions that
attenuate chemostimulation, for example by delaying the rise
in metabolic V˙CO2 (e.g., exercise training, Ferreira et al., 2009;
Dowman et al., 2013, 2014) or by reducing efferent output from
respiratory centers (e.g., O2 supplementation, opiates), alleviate
exertional dyspnea in patients with ILD (Visca et al., 2011; Bajwah
et al., 2013; O’Donnell et al., 2016).
PULMONARY ARTERIAL HYPERTENSION
(PAH)
Pulmonary hypertension is defined as a mean pulmonary artery
pressure (mPAP) ≥25 mmHg at rest as measured through
right heart catheterization (Hoeper et al., 2013). Although
still controversial, values >30 mmHg during exercise are
also deemed indicative of pulmonary hypertension (Hoeper,
2009). Pulmonary hypertension is consistently associated with
reduced exercise capacity (Miyamoto et al., 2000; Riley et al.,
2000a; Sun et al., 2001; Ferrazza et al., 2009). It has long
been known that peak V˙O2 and poor ventilatory efficiency
correlate significantly with morbidity and mortality in patients
with pulmonary hypertension (Schwaiblmair et al., 2012).
Frontiers in Physiology | www.frontiersin.org 12 February 2017 | Volume 8 | Article 82
O’Donnell et al. Exercise Testing for Lung Diseases
FIGURE 7 | Relation between dyspnea intensity (Borg units) and diaphragm electromyography (EMGdi) (A) and VT/IC (B) during incremental cycle exercise
test in patients with moderate COPD, ILD and age-matched healthy controls. (C) Shows the relation between VT/VC and EMGdi/EMGdi,max (an index of inspiratory
neural drive to the crural diaphragm); note the similar blunted VT/VC response to the increased neural drive in both ILD and COPD patients compared with healthy
subjects. Values are mean ± SEM. Square symbols represent tidal volume-ventilation inflection points. Selection frequency of descriptors of exertional dyspnea at
end-exercise in the three groups is shown in (D). *p < 0.05 for ILD vs. control subjects and †p < 0.05 for COPD vs. control subjects. COPD, chronic obstructive
pulmonary disease; IC, inspiratory capacity; VT, tidal volume; VC, vital capacity; ILD, interstitial lung disease. Reproduced from with permission from the publisher
(Faisal et al., 2016).
In this review, we will focus primarily on cardiopulmonary
response patterns in patients with increased PVR and PAP
in whom dynamic ventilatory mechanics are largely preserved
during exercise [e.g., idiopathic PAH (class 1) and chronic
thromboembolic pulmonary hypertension (class 4)]. We will
therefore exclude consideration of patients with pulmonary
hypertension secondary to primary cardiac diseases (class
2) or COPD or restrictive lung diseases (class 3). Typical
CPET findings in patients with PAH include (Figure 8):
(1) inefficient intra-pulmonary gas exchange; (2) variable
degrees of O2 desaturation; (3) hyperdynamic circulatory and
ventilatory responses; (4) reduced peak V˙O2 and/or impaired
rate of submaximal V˙O2; and (5) variable combinations of
leg effort and dyspnea as the limiting symptoms. Thus, PAH
is usually suspected when ventilatory responses to exercise
and the inspiratory neural drive to breathe are abnormally
elevated despite a relatively preserved maximal flow-volume
loop (Figure 9) (Theodore et al., 1986; Reybrouck et al., 1998;
Miyamoto et al., 2000; Riley et al., 2000a; Sun et al., 2001; Wensel
et al., 2002).
Increased Inspiratory Neural Drive during
Exercise in PAH: Increased
Chemostimulation
In patients with PAH, V˙E at any given submaximal exercise
intensity is increased, reflecting poor pulmonary perfusion
relative to ventilation (larger wasted ventilation) and, in
some patients, alveolar hyperventilation (low CO2 set-point)
(Theodore et al., 1986; Reybrouck et al., 1998; Sun et al., 2001;
Wensel et al., 2002). As in COPD and ILD, in PAH, high VD/VT
is related not only to increased areas of high V˙A/Q but also to
a low VT (see below). Thus, patients with PAH present with
poor ventilatory efficiency expressed either as a high V˙E/V˙CO2
nadir or a steep V˙E-V˙CO2 slope (Figure 8) (Reybrouck et al.,
1998; Mitani et al., 2002; Schwaiblmair et al., 2012). In most
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FIGURE 8 | Proposed panel displays for interpretation of key perceptual (A), ventilatory, and dynamic respiratory mechanical (B–I) responses to incremental
exercise test in patients with chronic respiratory diseases. Data showing these responses in a patient with pulmonary arterial hypertension (PAH) and an age and
gender matched healthy control. V˙E/V˙CO2, ventilatory equivalent for carbon dioxide; PETCO2, partial pressure of end-tidal carbon dioxide; SpO2, oxygen saturation
by pulse oximetry; Fb, breathing frequency; IRV, inspiratory reserve volume; TLC, total lung capacity.
patients, increased dyspnea scores at relatively low levels of
exercise are commensurate with the exaggerated increases in
ventilation. Thus, increased neural drive secondary to increased
chemostimulation is likely a keymechanism of increased dyspnea
intensity in PAH relative to healthy controls.
The V˙E-V˙CO2slope and V˙E/V˙CO2 nadir may further increase
if another source of ventilatory stimulus adds to the already-
increased inspiratory neural drive. As discussed below, the
ventilatory threshold is often lower in PAH than in health,
reflecting reduced O2 delivery (due to cardiac impairment)
to the active peripheral muscles and a greater reliance on
anaerobic glycolysis (Riley et al., 2000b). Significant skeletal
muscle deconditioning can arise as a result of dyspnea-related
inactivity in patients with PAH, which again may be associated
with an earlier metabolic acidosis and increased ventilatory
stimulation (de Jesus Perez, 2014).
Arterial O2 desaturations with widening of the A-aPO2
typically occur to a variable extent in patients with established
PAH (Riley et al., 2000a; Sun et al., 2001; Wensel et al., 2002).
The widened A-aPO2 reflects critical V˙A/Q inequalities and a
diffusion defect as a result of reduced red cell transit times
through the abnormal pulmonary vasculature (Riley et al., 2000a;
Sun et al., 2001; Wensel et al., 2002). Cardiac impairment in
PAH results in a lower mixed venous O2 saturation, which in the
setting of alveolar units with low V˙A/Q ratios negatively impacts
arterial oxygenation (Hoeper et al., 2007). Any concomitant
hypoxemia secondary to areas of low V˙A/Q or right-to-left shunt
(e.g., patent foramen ovale) may further increase ventilation
and compromise O2 delivery (Steenhuis et al., 2000; Hoeper
et al., 2007). PetCO2 levels are often diminished at higher levels
of exercise compared with health, reflecting relative alveolar
hyperventilation and dilution of expired CO2 (see the COPD
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section) (Riley et al., 2000b; Yasunobu et al., 2005; Hansen
et al., 2007). In fact, it has been suggested that PAH should be
suspected in patients who present with unexplained dyspnea and
exercise limitation whose PetCO2 at the ventilatory threshold is
<30mmHg (Yasunobu et al., 2005).
Abnormal Dynamic Respiratory Mechanics
during Exercise in PAH
One would anticipate that dynamic ventilatory mechanics during
exercise should not be abnormal in patients with PAH in the
absence of concomitant COPD or restrictive thoracic diseases.
However, it is conceivable that in some PAH patients with high
ventilatory demand and rapid breathing frequency, DH may
occur, particularly toward the end of exercise in the setting of
EFL. Indeed, recent studies have provided evidence that EFL,
DH, and restrictive mechanical constraints on VT expansion
can occur in a proportion of non-smokers with PAH with no
evidence of EFL at rest (Laveneziana et al., 2013a; Richter et al.,
2013; Laveneziana et al., 2015). As expected, these patients might
present with increased dyspnea intensity at any given ventilation.
In general, and perhaps surprisingly, breathing pattern
responses to exercise are usually more rapid and shallow in PAH
than in health (Laveneziana et al., 2013a). In many patients,
reduced VT expansion is not easily explained by restrictive
mechanics, as IRV is generally preserved or increased at peak
exercise compared with healthy controls. Relative tachypnea may
be related to activation of unmyelinated pulmonary C fibers
and/or altered mechanoreceptor inputs from the right heart and
pulmonary vasculature in a manner that remains incompletely
understood (Aguggini et al., 1987). Additionally, studies
have indicated that some patients with primary pulmonary
hypertension may show a mild restrictive spirometric pattern
as indicated by a modest reduction in TLC with preservation
of the FEV1/FVC ratio (Horn et al., 1983). The underlying
mechanism(s) remain unclear, but reduced lung compliance
and dynamic inspiratory respiratory muscle weakness have been
suggested as potential contributors (Phipps et al., 1983; Rich
et al., 1987; Polkey et al., 1995; Sun et al., 2003; Deboeck et al.,
2004; Escribano et al., 2005; Meyer et al., 2005). Regardless of the
mechanism(s), a shallow breathing pattern will amplify the effect
of a high VD on the VD/VT ratio and augment the increase in the
ventilatory drive.
Cardiovascular Responses to Exercise in
PAH
A healthy pulmonary vasculature is a prerequisite for
accommodating increased cardiac output during exercise while
minimizing increases in PVR. In PAH, high PAP (secondary to
the failure to recruit additional pulmonary vessels) and right
ventricular pressure overload (with potential leftward shift of
the interventricular septum) combine to impair the increase in
SV during exercise (Janicki, 1990; Holverda et al., 2006). Thus,
despite a compensatory increase in HR due to sympathetic
over-excitation, cardiac output may fail to adequately meet the
higher muscular demands for O2 (Janicki, 1990; Holverda et al.,
2006).
Impairments in peripheral O2 delivery to skeletal muscles
usually worsen as the demand for O2 increases, i.e., as exercise
becomes more intense. Consequently, patients with PAH may
present with a reduced slope of the relationship between V˙O2
andWR (1V˙O2/1WR<8–9ml.min
−1.watts−1) (Deboeck et al.,
2004; Yasunobu et al., 2005). In patients with advanced PAH,
1V˙O2/1WR plateaus or even decreases near the end of exercise.
The final consequence is a very low peak V˙O2 due to the
combination of low peak WR and decreased change in V˙O2
for a given change in WR. Impairment in O2 delivery may also
increase the contribution of anaerobic metabolism in the earlier
stages of exercise leading to greater increases in CO2 production
(from lactate buffering) for a given change in V˙O2, i.e., an early
lactate threshold (Deboeck et al., 2004; Yasunobu et al., 2005).
The impact of the tachycardic response on the 1HR/1V˙O2
relationship (O2 pulse, i.e., the amount of O2 taken in for a given
heart beat) depends on the ability of active skeletal muscle to
extract O2 from arterial blood and widened arterial-venous O2
difference (Wasserman et al., 1999). As most of the increase in
the arterial-venous O2 difference occurs during early exercise,
the HR/V˙O2 ratio during late exercise is chiefly influenced by
SV. Consequently, patients with PAH and impaired SV show a
flattened, downward-displaced O2 pulse profile (Janicki, 1990;
Wasserman et al., 1999; Deboeck et al., 2004; Yasunobu et al.,
2005; Holverda et al., 2006). In advanced disease, a flat O2 pulse
indicates a severely-impaired SV. The relative tachycardia that
remains during the recovery period, observed as a slowed post-
exercise HR decrease, has been found to be an ominous sign in
PAH (Riley et al., 2000b; Deboeck et al., 2004; Ramos et al., 2012).
Exertional Dyspnea in PAH
The mechanisms of exertional dyspnea in PAH are less well
studied than in the other chronic respiratory diseases. As
in COPD and ILD, existing data support an important role
of increased inspiratory neural drive, at least as indirectly
assessed by measures of ventilatory output. The increased drive
mainly reflects increased chemostimulation as a result of V˙/Q
abnormalities. In PAH, operating lung volumes are close to
normal but DH has also been described in some individuals
at higher exercise intensities (Laveneziana et al., 2013a; Richter
et al., 2013; Laveneziana et al., 2015). Regardless of the
mechanism of restriction, the inability to expand VT in response
to the increasing inspiratory neural drive (or inspired effort)
during exercise contributes importantly to low peak ventilatory
capacity and perceived respiratory discomfort. Traditionally, it
has also been assumed that direct afferent from the right ventricle
and pulmonary arterial afferents also play a contributory role, but
the data to support this are inconclusive (Aguggini et al., 1987).
It remains to be determined if neuro-mechanical dissociation
occurs in PAH at the limits of tolerance, and whether qualitative
descriptor choices are different from those of COPD and ILD.
COMPARISON OF EXERCISE RESPONSES
IN COPD, ILD AND PAH
At first glance, the four lung diseases under consideration
are remarkably different in their underlying pathology, static
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respiratory mechanics, nature and extent of the mechanical
load, respiratory muscle characteristics and recruitment patterns,
and pulmonary gas exchange. A comparison of the tidal
and maximal flow-volume loops during exercise allows easy
diagnostic differentiation (Figure 9). However, differences in
respiratorymechanics, inspiratory neural drive to the diaphragm,
ventilation, breathing pattern and the behavior of dynamic IRV
during conventional CPET are remarkably similar in obstructive
and restrictive diseases when compared to the healthy condition.
In COPD, VT is restricted by the effects of resting and dynamic
lung hyperinflation, whereas in ILD, the restriction is reflecting
the reduced TLC and IRV (Faisal et al., 2016) (Figures 3, 6).
Patients with ILD often have better preservation of inspiratory
muscle force-generating capacity, reflecting the mechanical
advantage of lower operating lung volumes (Faisal et al., 2016).
Furthermore, patients with ILD, unlike COPD patients, do not
usually have to contend with inspiratory threshold and resistive
loading. However, clinically stable ILD patients generally have
relatively greater tachypnea and often more severe gas exchange
abnormalities during exercise (O’Donnell et al., 2016). These
latter abnormalities generally occur earlier in ILD than COPD
and may precede the development of other resting pulmonary
function tests abnormalities.
Common Mechanisms of Dyspnea
In COPD and ILD, dyspnea during exercise fundamentally
reflects an imbalance between the increased demand to breathe
and the ability to meet that demand (Scano et al., 2010). The
rise in dyspnea intensity correlates closely with the following
physiological ratios: V˙E/MVC (maximum ventilatory capacity);
oesophageal pressure (Pes)/Pesmax; VT/IC or EILV/TLC; and
inspiratory neural drive to the diaphragm relative to maximum
(EMGdi/EMGdimax) (Figure 7) (Gandevia and Hugh-Jones,
1957; Leblanc et al., 1988; Laveneziana et al., 2013a; Guenette
et al., 2014; Elbehairy et al., 2016; Faisal et al., 2016). This
indicates that respiratory discomfort is provoked when there is
critical encroachment on reserves of ventilatory output, muscle
force generation, VT expansion or inspiratory neural drive to the
diaphragm (Gandevia andHugh-Jones, 1957; Leblanc et al., 1988;
Laveneziana et al., 2013a; Guenette et al., 2014; Faisal et al., 2016;
Elbehairy et al., 2016).
Current neurophysiological constructs propose that the
intensity of dyspnea rises with increasing tidal inspiratory
efferent neural activity relative to the maximum possible neural
activation (from bulbo-pontine and cortical motor centers in
the brain) as indirectly represented by the above physiological
ratios (Guenette et al., 2014; Elbehairy et al., 2016; Faisal
et al., 2016). Afferent neural inputs from multiple sensory
receptors throughout the respiratory system relay precise
information concerning the dynamic status of the respiratory
system (Caruana-Montaldo et al., 2000; Sant’Ambrogio and
Widdicombe, 2001; Widdicombe, 2009). An increase in motor
command to ventilatory muscles is perceived as a sensation of
respiratory work/effort, or dyspnea (Killian and Jones, 1984),
and the increase in ventilation (relative to maximal possible
ventilation) required to perform moderate or intense exercise is
accompanied by an increasing awareness of increased work or
effort of breathing, even in healthy subjects (Killian, 1998). It is
further postulated that concomitant increased central corollary
discharge from cortical and bulbo-pontine control centers to the
somato-sensory cortex, where unpleasant respiratory sensations
are consciously perceived, is a final common pathway (Killian
et al., 1984; Chen et al., 1992; Banzett et al., 2008).
At exercise termination in both COPD and ILD, central
respiratory efferent drive reaches almost maximal values, but the
respiratory muscle pump, which is overloaded or functionally
weakened, responds inadequately to the increased electrical
activation. Thus, despite near maximal drive and effort, very little
FIGURE 9 | Typical flow-volume curves in (A): a healthy subject and patients with (B) COPD, (C) ILD, and (D) PAH. In the patient with COPD, there is a leftward
shift of the curve with noticeable expiratory flow limitation during exercise (i.e., tidal loops at peak exercise exceed maximal expiratory envelope). In the patient with
ILD, there is a rightward shift of the curve with no expiratory flow limitation and adequate reserves of inspiratory and expiratory flow at end exercise. Note the markedly
reduced inspiratory reserve volume (IRV) in both ILD and COPD patients compared with healthy subject (IRV, TLC-end-inspiratory lung volume). In PAH; the
flow-volume curve is close to the healthy subject due to absence of respiratory mechanical problem in most classical cases. Solid lines, maximal and tidal loops at
rest; dashed lines, tidal loops at peak exercise; dotted lines, predicted normal maximal expiratory loop. COPD, chronic obstructive pulmonary disease; ILD, interstitial
lung disease; TLC, total lung capacity; RV, residual volume; IC, inspiratory capacity; PAH, pulmonary arterial hypertension. Reproduced with permission from the
publisher (O’Donnell et al., 1997, 1998).
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air enters the lungs with each breath (Figure 7) (Faisal et al.,
2016). This disparity is perceived as unpleasant and is the result
of central integration of efferent central outputs and multiple
afferent peripheral inputs from the respiratorymuscles, chest wall
and lungs (Carrieri-Kohlman et al., 2001; Widdicombe, 2009). In
line with this theory, it has been repeatedly shown that external
imposition of mechanical loads to impede respiration in healthy
volunteers in the face of increasing chemostimulation reliably
provokes respiratory sensations akin to “unsatisfied inspiration”
(Figure 7) (O’Donnell et al., 1997, 1998; Faisal et al., 2016). In
contrast to obstructive and restrictive lung diseases, dyspnea
during activity in PAH appears to be more closely related to
the increased inspiratory neural drive reflecting pulmonary gas
exchange and cardio-circulatory abnormalities than to deranged
mechanics, per se (Aguggini et al., 1987).
Although definitive experimental verification is lacking, it is
believed that vagal afferent input from the lungs and pulmonary
vasculature directly to the somato-sensory cortex, or spinal input
from mechanoreceptors in the respiratory muscles and chest
wall, can directly induce unpleasant respiratory sensations that
shape the clinical expression of dyspnea in all three conditions
(Adrian, 1933; Killian et al., 1984; Chen et al., 1992; Chen and
Kou, 2000; Banzett et al., 2008; Lee, 2009). Indeed, activation
of the pulmonary C fibers and the high-threshold A Delta
fibers may alter breathing pattern and contribute to dyspnea
(Yu, 2009; Lee and Yu, 2014). Activation of those pulmonary
afferents may cause further DH by inducing tachypnea (Yu et al.,
1998; Soukhova et al., 1999; Yu, 2000) or by suppression of
expiratory muscle activity, thus adding more burdens on the
inspiratory muscles (Yu et al., 2001). Notwithstanding, a recent
study provides strong evidence that the relationship between
increased dyspnea intensity and increased inspiratory neural
drive to the diaphragm during exercise is not affected by major
disease-specific differences in afferent inputs from the airways,
lung parenchyma, chest wall, and respiratory muscles (Figure 7)
(Faisal et al., 2016). Additionally, respiratory discomfort beyond
a certain threshold evokes emotive responses, such as anxiety,
fear, panic or distress. The threshold of the affective distress
likely varies between individuals and is thought to be linked to
increased activation of limbic and paralimbic centers in the brain
and associated over-activation of the sympathetic nervous system
(Banzett et al., 2000; von Leupoldt et al., 2008).
SUMMARY AND CLINICAL IMPLICATIONS
Based on solid physiological principles established by
foundational researchers in the field, such as Wasserman
and Whipp (Wasserman et al., 1999), CPET interpretation
has traditionally focused on measuring peak V˙O2 and has
incorporated quantitative assessments of cardiac and ventilatory
reserves as well as aerobic capacity. The simple format proposed
here extends this approach to include evaluation of perceived
intensity of exertional dyspnea and its physiological origins in an
individual presenting with respiratory symptoms. This approach
is focused on uncovering integrated pathophysiological
abnormalities that help explain the origins of dyspnea and
exercise intolerance in the individual and is less concerned with
diagnostic differentiation. Specifically, analysis of ventilatory
efficiency, breathing pattern and operating lung volumes
throughout exercise permits a useful non-invasive assessment
of pulmonary gas exchange and the prevailing respiratory
mechanical constraints which are known to contribute to
dyspnea perception. In this context, measurement of operating
lung volumes throughout exercise is arguably more sensitive
than traditional assessments of breathing reserve (V˙E/MVC), at
least in patients with earlier or milder COPD and ILD (Dempsey,
2013; Faisal et al., 2016).
The physiological perturbations of early COPD and
ILD are generally akin to the effects of accelerated aging:
age-related pulmonary gas exchange and mechanical
derangements are exaggerated, and inspiratory neural drive
and attendant exertional dyspnea become amplified at any
given work rate. Indeed, we believe that an exercise challenge
test that incorporates the above-outlined measurements
allows a comprehensive physiological characterization of
pathophysiology in symptomatic patients in the early phases of
COPD, ILD, and PAH, whose resting pulmonary function tests
are close to the normal range. Using this approach, it is possible
to uncover unanticipated abnormalities such as dynamic lung
hyperinflation and attendant mechanical constraints, which
require further diagnostic evaluation and targeted treatment. For
example, the finding of DH in a symptomatic patient with ILD
or PAH might lead to a therapeutic trial of a bronchodilator.
Knowledge of the commonmechanisms of exertional dyspnea
in COPD, ILD, and PAH enables the development of a
cogent physiological rationale for personalized management.
Thus, interventions that reduce the heightened inspiratory
neural drive (exercise training, supplemental O2, or opioid
medication) can successfully ameliorate dyspnea during physical
activity in selected patients. Similarly, interventions that
improve respiratory mechanics and dynamic respiratory muscle
function (e.g., bronchodilators in COPD, specific inspiratory
muscle training in selected patients with measurable weakness)
can enhance neuro-mechanical coupling of the respiratory
system and improve dyspnea and exercise intolerance. Finally,
identification of heterogeneous physiological derangements of
pulmonary gas exchange andmechanics during exercise earlier in
the course of these common chronic respiratory diseases sets the
stage for more precise clinical phenotyping of patients and raises
the prospect of developing targeted therapeutic interventions and
evaluating their clinical efficacy.
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